91 related articles for article (PubMed ID: 19211266)
1. Relationship between circulating levels of monocyte chemoattractant protein-1 and systolic dysfunction in patients with hypertrophic cardiomyopathy.
Iwasaki J; Nakamura K; Matsubara H; Nakamura Y; Nishii N; Banba K; Murakami M; Ohta-Ogo K; Kimura H; Toh N; Nagase S; Oka T; Morita H; Kusano KF; Ohe T
Cardiovasc Pathol; 2009; 18(6):317-22. PubMed ID: 19211266
[TBL] [Abstract][Full Text] [Related]
2. Expression of monocyte chemoattractant protein-1 in idiopathic dilated cardiomyopathy.
Kobayashi M; Nakamura K; Kusano KF; Nakamura Y; Ohta-Ogo K; Nagase S; Sakuragi S; Ohe T
Int J Cardiol; 2008 Jun; 126(3):427-9. PubMed ID: 17467829
[TBL] [Abstract][Full Text] [Related]
3. Monocyte chemoattractant protein 1 (MCP-1) gene expression in dilated cardiomyopathy.
Lehmann MH; Kühnert H; Müller S; Sigusch HH
Cytokine; 1998 Oct; 10(10):739-46. PubMed ID: 9811526
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin acts as a positive indicator of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy.
Unno K; Shibata R; Izawa H; Hirashiki A; Murase Y; Yamada T; Kobayashi M; Noda A; Nagata K; Ouchi N; Murohara T
Heart; 2010 Mar; 96(5):357-61. PubMed ID: 19648128
[TBL] [Abstract][Full Text] [Related]
5. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
[TBL] [Abstract][Full Text] [Related]
6. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular diastolic function assessed with cardiovascular magnetic resonance imaging and exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy.
Małek LA; Chojnowska L; Kłopotowski M; Misko J; Dabrowski M; Kuśmierczyk-Droszcz B; Maczyńska R; Piotrowicz E; Ruzyłło W
Kardiol Pol; 2009 Jan; 67(1):1-6; discussion 7-8. PubMed ID: 19253184
[TBL] [Abstract][Full Text] [Related]
8. Relationship between oxidative stress and systolic dysfunction in patients with hypertrophic cardiomyopathy.
Nakamura K; Kusano KF; Matsubara H; Nakamura Y; Miura A; Nishii N; Banba K; Nagase S; Miyaji K; Morita H; Saito H; Emori T; Ohe T
J Card Fail; 2005 Mar; 11(2):117-23. PubMed ID: 15732031
[TBL] [Abstract][Full Text] [Related]
9. [Early diastolic dysfunction of the left ventricle affected by hypertrophy and abnormal histopathology in hypertrophic cardiomyopathy].
Sugihara N; Shimizu M; Suematsu T; Horita Y; Shimizu K; Ohsato K; Shibayama S; Nakao T; Kitamura M; Takeda R
J Cardiol; 1990; 20(1):71-81. PubMed ID: 2151236
[TBL] [Abstract][Full Text] [Related]
10. [Advanced sequelae of apical hypertrophic cardiomyopathy: report of two cases with wall motion abnormalities].
Kusukawa J; Suwa M; Nakayama Y; Hirota Y; Kawamura K; Adachi I; Akagi H
J Cardiol; 1988 Mar; 18(1):259-69. PubMed ID: 3221316
[TBL] [Abstract][Full Text] [Related]
11. [Hypertrophic cardiomyopathy with left ventricular dilatation].
Iwami G; Miyazaki Y; Matsuyama K; Shida M; Ooga M; Furuta Y; Ikeda H; Toshima H; Chiba M; Koga Y
J Cardiol; 1988 Jun; 18(2):319-28. PubMed ID: 3249261
[TBL] [Abstract][Full Text] [Related]
12. B-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy.
Kaski JP; Tomé-Esteban MT; Mead-Regan S; Pantazis A; Marek J; Deanfield JE; McKenna WJ; Elliott PM
Heart; 2008 Oct; 94(10):1307-11. PubMed ID: 18070943
[TBL] [Abstract][Full Text] [Related]
13. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
[TBL] [Abstract][Full Text] [Related]
14. Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function.
Pieroni M; Corti A; Tota B; Curnis F; Angelone T; Colombo B; Cerra MC; Bellocci F; Crea F; Maseri A
Eur Heart J; 2007 May; 28(9):1117-27. PubMed ID: 17389654
[TBL] [Abstract][Full Text] [Related]
15. Steep left ventricle to aortic root angle and hypertrophic obstructive cardiomyopathy: study of a novel association using three-dimensional multimodality imaging.
Kwon DH; Smedira NG; Popovic ZB; Lytle BW; Setser RM; Thamilarasan M; Schoenhagen P; Flamm SD; Lever HM; Desai MY
Heart; 2009 Nov; 95(21):1784-91. PubMed ID: 19549621
[TBL] [Abstract][Full Text] [Related]
16. Exercise-induced ST-segment depression and systolic dysfunction in patients with nonobstructive hypertrophic cardiomyopathy.
Shimizu M; Ino H; Okeie K; Emoto Y; Yamaguchi M; Yasuda T; Fujino N; Fujii H; Fujita S; Mabuchi T; Taki J; Mabuchi H
Am Heart J; 2000 Jul; 140(1):52-60. PubMed ID: 10874263
[TBL] [Abstract][Full Text] [Related]
17. Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes.
Poutanen T; Tikanoja T; Jääskeläinen P; Jokinen E; Silvast A; Laakso M; Kuusisto J
Am Heart J; 2006 Mar; 151(3):725.e1-725.e9. PubMed ID: 16504640
[TBL] [Abstract][Full Text] [Related]
18. [Aortic regurgitation in hypertrophic cardiomyopathy as detected by color Doppler echocardiography].
Shiota T; Sakamoto T; Amano K; Hada Y; Takenaka K; Hasegawa I; Takahashi T; Suzuki J; Takahashi H; Sugimoto T
J Cardiol; 1987 Dec; 17(4):759-68. PubMed ID: 3506602
[TBL] [Abstract][Full Text] [Related]
19. Myocardial collagen type I and impaired left ventricular function under exercise in hypertrophic cardiomyopathy.
Mundhenke M; Schwartzkopff B; Stark P; Schulte HD; Strauer BE
Thorac Cardiovasc Surg; 2002 Aug; 50(4):216-22. PubMed ID: 12165871
[TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor-alpha soluble receptors type I are related to symptoms and left ventricular function in hypertrophic cardiomyopathy.
Penicka M; Gregor P; Krupicka J; Jira M
Can J Cardiol; 2001 Jul; 17(7):777-84. PubMed ID: 11468644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
